Pelican Pharma And Surgicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 M
- Revenue Growth 362.84%
- Profit Growth 93.39%
- Ebitda 29.70%
- Net Worth 22.01%
- Total Assets -5.59%
About Pelican Pharma And Surgicals
Pelican Pharma And Surgicals Private Limited (PPASPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 August 2021 (Three years and five months 13 days old ). Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.50 M.
Baiju Subramanian and Satheesh Nair serve as directors at the Company.
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U52590KL2021PTC070463
- Company No.
070463
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Aug 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Pelican Pharma And Surgicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Baiju Subramanian  | Director | 19-Aug-2021 | Current |
| Satheesh Nair | Director | 19-Aug-2021 | Current |
Financial Performance of Pelican Pharma And Surgicals.
Pelican Pharma And Surgicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 362.84% increase. The company also saw a substantial improvement in profitability, with a 93.39% increase in profit. The company's net worth Soared by an impressive increase of 22.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pelican Pharma And Surgicals?
Unlock access to Pelican Pharma And Surgicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Janet Healthcare Private LimitedBaiju Subramanian and Satheesh Nair are mutual person
Charges (Loans)
₹3.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jul 2023 | Others | ₹3.50 M | Open |
How Many Employees Work at Pelican Pharma And Surgicals?
Pelican Pharma And Surgicals has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pelican Pharma And Surgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pelican Pharma And Surgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.